![]() |
CardioComm Solutions Inc. Opens Office in Toronto , Ont---Management & Operations Re-Organized to Save $300,000 Annually.
|
|
VICTORIA, B.C., August 15, 2007 – CardioComm Solutions Inc. (TSX-V:CCG) ("CardioComm", the “Company”), is pleased to announce that it will open a second office in Toronto , Ontario this month. The Company will transfer its Corporate Development and Accounting functions to the Toronto office while the GEMS™ development team, sales, support and head office will remain in Victoria , B.C. This re-organization enhances efficiencies and reduces duplication of duties. Overall, these changes are anticipated to reduce annual overheads by approximately C$300,000.
In association with these changes, the Company wishes to thank Mr. Adrian Somers, Vice-President, Corporate Development for many valuable years of service. Mr. Somers will be continuing with the Company effective this September as a Senior Consultant to Cardiocomm.. The Company also wishes to confirm that Mr. Stephen Martin, CEO, has had his salary reduced by 45%.
The Company's efforts are focused on the current trials of its GC 12 lead initiative which is expected to be fully launched in the autumn. The Company will issue a future release concerning this in due course.
About CardioComm Solutions Inc. CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.
|
On behalf of the Board of Directors of CardioComm Solutions Inc.
“Stephen Martin”
Stephen R. Martin, President & CEO
For investor information, please contact: Stephen Martin Copyright © 2007CardioComm Solutions Inc. All rights reserved
|